Ono
Ono Pharmaceutical Co., Ltd., commonly referred to as Ono, is a prominent player in the biopharmaceutical industry, headquartered in Osaka, Japan. Founded in 1717, Ono has established itself as a leader in innovative drug development, particularly in oncology and immunology. The company has made significant strides with key milestones, including the successful launch of its flagship product, Opdivo, which has transformed cancer treatment paradigms. Ono's core offerings focus on cutting-edge therapies that address unmet medical needs, setting them apart through rigorous research and development. With a strong presence in Japan and expanding operations in global markets, Ono has garnered recognition for its commitment to advancing healthcare. The company’s dedication to innovation and patient-centric solutions has solidified its position as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Ono's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ono's score of 32 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ono's reported carbon emissions
In 2023, Ono reported total carbon emissions of approximately 16,000,000 kg CO2e, comprising 6,600,000 kg CO2e from Scope 1, 9,400,000 kg CO2e from Scope 2, and 16,000,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions included significant contributions from capital goods (18,400,000 kg CO2e) and business travel (3,100,000 kg CO2e). Comparatively, in 2022, Ono's total emissions were about 18,400,000 kg CO2e, with Scope 1 emissions at 8,000,000 kg CO2e and Scope 2 at 10,200,000 kg CO2e. The Scope 3 emissions for that year were notably high, particularly from capital goods (21,300,000 kg CO2e) and business travel (1,300,000 kg CO2e). In 2021, the company reported total emissions of approximately 23,600,000 kg CO2e, with Scope 1 emissions at 9,800,000 kg CO2e and Scope 2 at 13,700,000 kg CO2e. The Scope 3 emissions were substantial, particularly from capital goods (26,400,000 kg CO2e). Despite these figures, Ono has not disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further clarity on their long-term climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 9,800,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,700,000 | 00,000,000 | 0,000,000 |
| Scope 3 | 52,100,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ono is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
